Financing ·
Jaguar Health issues ~1.46M shares to Streeterville Capital to retire $6.73M of debt
JAGXJaguar Health, Inc.
Jaguar Health, Inc. entered into exchange agreements with Streeterville Capital, LLC to reduce its debt obligations by issuing common stock. The company issued 182,091 shares to reduce the outstanding balance of the 2021 Note by $1,678,320 and issued 547,898 shares to fully pay off and cancel the 2025 Note, reducing its balance by $5,049,909. Following these transactions, approximately 1,463,958 shares of common stock were issued and outstanding as of September 24, 2026. Jaguar Health operates in the pharmaceutical industry, developing treatments for gastrointestinal disorders.